Form 4: Utz Director Exercises Warrants, Boosts Stake

Sentiment:

Insider Transaction Report


Utz Brands Director Roger K. Deromedi exercised 2.4 million warrants, resulting in a net increase of 433,347 Class A Common Stock shares in his beneficial ownership.

Summary

  • Director Roger K. Deromedi exercised 2,400,000 warrants to purchase Class A Common Stock of Utz Brands, Inc. on August 8, 2025, as part of a pre-scheduled Rule 10b5-1 plan.
  • The exercise price for the warrants was $11.5 per share.
  • In connection with the cashless exercise, 1,966,653 shares of Class A common stock were "withheld" to cover the exercise cost.
  • This transaction resulted in a net increase of 433,347 shares of Class A Common Stock in Mr. Deromedi's beneficial ownership.
  • Following these transactions, Mr. Deromedi's total beneficial ownership across various trusts and direct holdings is approximately 6,389,211 shares of Class A Common Stock (excluding 360,000 shares held by an Irrevocable Trust where beneficial ownership is disclaimed).
  • All 2,400,000 warrants held by Mr. Deromedi were exercised, leaving 0 warrants remaining.
  • The warrants were exercisable at any time and expire on August 28, 2025, or earlier upon redemption or liquidation of the Issuer.

Sentiment

Score: 7

Explanation: The exercise of warrants by a director, resulting in a net increase in beneficial ownership, generally indicates confidence in the company's future prospects. The pre-scheduled nature of the transaction (10b5-1 plan) suggests a long-term view rather than a reaction to immediate market conditions, which is a positive signal from an insider.

Positives

  • Director Roger K. Deromedi increased his beneficial ownership of Utz Brands Class A Common Stock by a net of 433,347 shares through a pre-scheduled warrant exercise, indicating planned confidence in the company.
  • The exercise of warrants at $11.5 suggests a belief in the stock's value above this price by a key insider.

Negatives

  • A significant portion of shares (1,966,653) were withheld in a cashless exercise, which means these shares did not directly convert into cash for the insider.

Risks

  • Warrants were exercisable at any time and expired on August 28, 2025, or earlier upon redemption or the liquidation of the Issuer, which is a standard characteristic of such derivative securities.

Future Outlook

The filing is a Form 4 reporting an insider transaction and does not provide forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This Form 4 filing reports an insider transaction, specifically a director's exercise of warrants and subsequent share acquisition. Such transactions, especially when pre-scheduled under a 10b5-1 plan, are common and typically reflect an insider's long-term view on the company's valuation. It does not provide broader industry trends or competitive analysis.

Stakeholder Impact

  • Shareholders: The increase in director ownership may be viewed positively as a sign of confidence in the company's future.

Next Steps

  • The filing does not mention any specific future actions, events, or milestones for the company or the reporting person beyond the warrant expiration date.

Key Dates

DateDescription
2000-02-11Original date of the Roger K. Deromedi Revocable Trust.
2011-11-09Amended and Restated date of the Roger K. Deromedi Revocable Trust.
2018-10-04Date of the Warrant Agreement between Collier Creek Holdings and Continental Stock Transfer & Trust Company.
2020-10-01Date of the Roger K. Deromedi Irrevocable Generation Skipping Trust.
2021-11-01Date of the Roger K. Deromedi Irrevocable Grantor Retained Annuity Trust (2021 GRAT).
2022-02-22Date of Assignment and Assumption Agreement for the Warrant Agreement.
2024-02-22Date of The Roger K. Deromedi Irrevocable Grantor Retained Annuity Trust (2024 GRAT 1).
2024-11-19Date of the Roger K Deromedi Irrevocable Grantor Retained Annuity Trust (2024 GRAT 2).
2025-08-08Date of warrant exercise and share transactions, executed pursuant to a Rule 10b5-1 plan.
2025-08-11Date the Form 4 was filed.
2025-08-28Warrants expiration date.

Recommendation

hold

The director's decision to exercise warrants and increase their beneficial ownership suggests confidence in Utz Brands' future. However, a Form 4 filing provides limited financial and operational data, making it insufficient to issue a 'buy' or 'sell' recommendation. Investors should consider this insider activity as a positive signal but combine it with a broader analysis of the company's financial performance, market conditions, and strategic outlook before making investment decisions. Therefore, a 'hold' recommendation is appropriate, indicating that existing investors might maintain their positions while new investors should seek more comprehensive data.

Keywords

Utz Brands, UTZ, Insider Trading, Form 4, Warrant Exercise, Beneficial Ownership, Director, Roger K. Deromedi, Class A Common Stock, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.